These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


360 related items for PubMed ID: 56399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K, Nakashima I, Nagase F, Isobe K, Kawashima K, Hasegawa Y, Yoshida T, Iwamoto T, Hasegawa T, Muro Y.
    J Immunol; 1988 Feb 01; 140(3):723-9. PubMed ID: 2448374
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes.
    Scott JW, Ponzio NM, Orosz CG, Finke JH.
    J Immunol; 1980 May 01; 124(5):2378-83. PubMed ID: 6444971
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated immune response in vitro. I. The development of suppressor cells and cytotoxic lymphocytes in mixed lymphocyte cultures.
    Hirano T, Nordin AA.
    J Immunol; 1976 Apr 01; 116(4):1115-22. PubMed ID: 130426
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Frequency and cross-reactivity od cytolytic T lymphocyte precursors reacting against male alloantigens.
    Kanagawa O, Louis J, Cerottini JC.
    J Immunol; 1982 May 01; 128(5):2362-6. PubMed ID: 6174631
    [Abstract] [Full Text] [Related]

  • 10. Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes.
    Hirano T, Nordin AA.
    J Immunol; 1976 Dec 01; 117(6):2226-32. PubMed ID: 62810
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alloantigen pretreatment induces a down-regulation of the in vivo subsequent development of cytotoxic T lymphocytes directed against linked alloantigens.
    Schutze MP, Langlade-Demoyen P, Przewlocki G, Leclerc C.
    Eur J Immunol; 1989 Aug 01; 19(8):1365-71. PubMed ID: 2789138
    [Abstract] [Full Text] [Related]

  • 15. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H, Kubota E, Suzuki H, Saito K.
    J Immunol; 1985 May 01; 134(5):2953-9. PubMed ID: 2580009
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FCS-activated blast T cells inhibit the in vitro response of memory CTL precursors to alloantigens by removal of factor(s) from MLC supernatant.
    Degiovanni G, Schaaf-Lafontaine N.
    J Immunol; 1981 Feb 01; 126(2):641-7. PubMed ID: 6450247
    [Abstract] [Full Text] [Related]

  • 18. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC.
    J Immunol; 1985 Jul 01; 135(1):53-62. PubMed ID: 3158707
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM, Chandrasekaran J.
    J Immunol; 1987 Aug 01; 139(3):905-12. PubMed ID: 2955052
    [Abstract] [Full Text] [Related]

  • 20. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL, Darrow TL, Scott DW.
    J Immunol; 1983 Jun 01; 130(6):2982-6. PubMed ID: 6189910
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.